IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $9.7 million in its second quarter.
On a per-share basis, the Irvine, California-based company said it had a loss of 30 cents.
The cancer diagnostic test developer posted revenue of $518,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX
/AI%20(artificial%20intelligence)/Data%20Center%20by%20Caureem%20via%20Shutterstock%20(2).jpg)
/A%20corporate%20sign%20for%20SK%20Hynix%20by%20Tada%20Images%20via%20Adobe%20Stock.jpeg)
/AI%20(artificial%20intelligence)/Ai%20chip%20by%20Quality%20Stock%20Arts%20via%20Shutterstock.jpg)